Answers are grounded in this paper and cite their sources.
Reveals the minimum CMA enhancement required for effective therapy in Parkinson's disease, suggesting a crucial treatment threshold.
A 2D nonlinear ODE model of chaperone-mediated autophagy (CMA) dynamics reveals a saddle-node bifurcation at k₁,max = 0.433 h⁻¹ (8.7× PD baseline). Below this threshold no healthy attractor exists. The model predicts a treatment window defined by αSyn monomer burden at therapy initiation, independently verified by scipy. Includes cross-disease isomorphism finding with NLRP3/Alzheimer's disease (fold-change ratio 1.09). Generated by the Metascientist autonomous discovery pipeline.
No takes yet. Share an insight, caveat, or question.
Navin Dutta (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: